Medical conditions are specified in List. Specified medical conditions associated with increased risk of invasive meningococcal disease.

Age at start of vaccine course

MenACWY vaccine brand

Dose requirements for healthy people (without any medical conditions associated with increased risk of invasive meningococcal disease)

6 weeks to 5 months

Menveo

Nimenrix

3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age)

6–8 months

Menveo

Nimenrix

2 doses (2nd dose at 12 months of age or 8 weeks after 1st dose, whichever is later)

9–11 months

Menveo

Nimenrix

Menactra

2 doses (2nd dose at 12 months of age or 8 weeks after 1st dose, whichever is later)

12–23 months

Menveo

2 doses (8 weeks between doses)

Nimenrix

1 dose

Menactra

2 doses (8 weeks between doses)

Last updated: 
5 June 2018
Last reviewed: 
5 June 2018